Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Pb Multiple | -0.1x - -0.1x | -0.1x |
| Historical Pb Multiple | -0.1x - 0.0x | -0.1x |
| Fair Value | ₹15.40 - ₹17.02 | ₹16.21 |
| Upside | 20.8% - 33.5% | 27.1% |
| Benchmarks | - | Full Ticker |
| Morepen Laboratories Limited | 50,028,800.0% | BSE:500288 |
| Supriya Lifescience Limited | 54,343,400.0% | BSE:543434 |
| SMS Pharmaceuticals Limited | 53,281,500.0% | BSE:532815 |
| Shilpa Medicare Limited | 53,054,900.0% | BSE:530549 |
| Anuh Pharma Limited | 50,626,000.0% | BSE:506260 |
| Ind-Swift Limited | - | NSEI:INDSWFTLTD |
| Select Price / Book Ratio | ||||||||
| Benchmark Companies | ||||||||
| 500288 | 543434 | 532815 | 530549 | 506260 | INDSWFTLTD | |||
| BSE:500288 | BSE:543434 | BSE:532815 | BSE:530549 | BSE:506260 | NSEI:INDSWFTLTD | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | 27.2% | 24.7% | 4.5% | -22.3% | 20.8% | 11.7% | ||
| 3Y CAGR | -0.3% | -1.2% | -7.3% | -40.0% | 28.3% | NM- | ||
| Latest Twelve Months | 65.5% | 44.9% | 83.3% | 13263.4% | -7.5% | 116.2% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 5.7% | 24.3% | 7.1% | 6.9% | 6.9% | -0.9% | ||
| Prior Fiscal Year | 2.7% | 19.5% | -1.4% | -3.1% | 6.9% | 6.3% | ||
| Latest Fiscal Year | 5.7% | 20.9% | 7.0% | 2.8% | 9.3% | 2.8% | ||
| Latest Twelve Months | 7.1% | 26.0% | 8.5% | 7.1% | 8.0% | 12.7% | ||
| Return on Equity | ||||||||
| 5 Year Average Margin | 16.5% | 21.9% | 10.0% | 4.8% | 16.3% | NA | ||
| Prior Fiscal Year | 5.8% | 13.7% | -1.5% | -1.8% | 15.9% | NM | ||
| Latest Twelve Months | 13.3% | 21.0% | 12.7% | 4.3% | 18.0% | NM | ||
| Next Fiscal Year | 13.9% | 19.3% | 13.8% | 7.1% | 23.5% | -3.2% | ||
| Two Fiscal Years Forward | 14.4% | 16.9% | 15.6% | 10.1% | 22.6% | -3.9% | ||
| Current Trading Multiples | ||||||||
| Price / LTM Sales | 1.5x | 8.6x | 2.3x | 4.8x | 1.2x | 0.1x | ||
| Price / LTM EPS | 20.8x | 33.2x | 26.6x | 67.2x | 14.9x | 1.1x | ||
| Price / Book | 2.4x | 6.4x | 3.1x | 2.5x | 2.5x | -0.1x | ||
| Price / Fwd Book | 2.7x | 6.0x | 2.9x | 3.1x | 2.1x | -0.1x | ||
| Low | Mid | High | ||||||
| Benchmark P/B Ratio | 2.4x | 2.5x | 6.4x | |||||
| Historical P/B Ratio | -0.1x | -0.1x | 0.0x | |||||
| Selected P/B Multiple | -0.1x | -0.1x | -0.1x | |||||
| (x) Book Value | (6,585) | (6,585) | (6,585) | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 500288 | 543434 | 532815 | 530549 | 506260 | INDSWFTLTD | |
| Value of Common Equity | 26,598 | 59,123 | 17,701 | 59,290 | 7,479 | 691 | |
| (/) Shares Outstanding | 548.0 | 80.5 | 84.7 | 86.8 | 50.1 | 54.2 | |
| Implied Stock Price | 48.54 | 734.60 | 209.10 | 683.05 | 149.25 | 12.75 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 48.54 | 734.60 | 209.10 | 683.05 | 149.25 | 12.75 | |
| Trading Currency | INR | INR | INR | INR | INR | INR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |